- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
SLTM Market Currents
more »
-
March 7 Solta Medical (SLTM) +5.8% premarket after providing an update of the launch of its FDA-approved Liposonix non-invasive fat reduction system. SLTM says it is on track to meet or exceed 2012 revenue guidance, and the majority of key opinion leaders who received Liposonix systems have successfully evaluated and purchased the product.
Comment![Healthcare, On the Move]
SLTM in Focus
more »
SLTM Related Articles
more »
SLTM News
more »
-
at MarketWatch.com (Dec 15, 2010)
SLTM Press Releases and Filings
more »
-
PR Newswire (May 1, 2012)
-
PR Newswire (Apr 19, 2012)
-
PR Newswire (Apr 17, 2012)
-
PR Newswire (Mar 19, 2012)
-
PR Newswire (Jan 11, 2012)
SLTM Latest Transcript
more »
SLTM Cramer
more »
Currently, there are no Cramer articles on SLTM.
SLTM Instablog posts
more »
SLTM vs. ETF Alternatives
Company Description
Currently, there's no company description for SLTM.
